Eris Lifesciences
₹843.35
2.35 (0.28%)
- Advice
- Hold
29 March, 2024 05:26 BSE: 540596
NSE: ERISISIN: INE406M01024
Start SIP in Eris Lifesciences
Start SIPEris Lifesciences Performance
Day Range
- Low 832
- High 862
52 Week Range
- Low 566
- High 972
- Open Price848
- Previous Close841
- Volume59652
Eris Lifesciences Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 316 | 410 | 411 | 308 |
Operating Expenses Qtr Cr | 250 | 265 | 256 | 203 |
Operating Profit Qtr Cr | 74 | 144 | 156 | 111 |
Depreciation Qtr Cr | 28 | 25 | 20 | 17 |
Interest Qtr Cr | 15 | 7 | 7 | 3 |
Tax Qtr Cr | 3 | 2 | 22 | 8 |
Net Profit Qtr Cr | 32 | 118 | 111 | 88 |
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹843.35
2.35 (0.28%)
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹858.19
- 50 Day
- ₹873.71
- 100 Day
- ₹872.07
- 200 Day
- ₹837.29
- 20 Day
- ₹864.61
- 50 Day
- ₹880.07
- 100 Day
- ₹893.72
- 200 Day
- ₹842.71
Eris Lifesciences Resistance and Support
PIVOT
₹845.84
Resistance | |
---|---|
First Resistance | 859.67 |
Second Resistance | 875.98 |
Third Resistance | 889.82 |
RSI | 41.74 |
MFI | 55.55 |
MACD Single Line | -10.62 |
MACD | -12.16 |
Support | |
---|---|
First Resistance | 829.52 |
Second Resistance | 815.68 |
Third Resistance | 799.37 |
Eris Lifesciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 69,460 | 3,392,426 | 48.84 |
Week | 78,311 | 4,693,961 | 59.94 |
1 Month | 192,367 | 9,616,417 | 49.99 |
6 Month | 231,887 | 11,765,927 | 50.74 |
Eris Lifesciences Result Highlights
Eris Lifesciences Synopsis
NSE-Medical-Biomed/Biotech
Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1330.73 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2023. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.Market Cap | 11,472 |
Sales | 1,460 |
Shares in Float | 6.12 |
No of funds | 126 |
Yield |
Book Value | 5.12 |
U/D Vol ratio | 0.5 |
LTDebt / Equity | 9 |
Alpha | 0.07 |
Beta | 0.67 |
Eris Lifesciences
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 54.9% | 54.91% | 52.86% | 52.86% |
Mutual Funds | 13.85% | 13.86% | 10.27% | 9.64% |
Insurance Companies | 0.01% | |||
Foreign Portfolio Investors | 13.13% | 13.2% | 13.78% | 14.86% |
Financial Institutions/ Banks | ||||
Individual Investors | 15.67% | 15.47% | 22.07% | 21.66% |
Others | 2.45% | 2.56% | 1.01% | 0.98% |
Eris Lifesciences Management
Name | Designation |
---|---|
Mr. Amit Bakshi | Chairperson & Managing Director |
Mr. Krishnakumar Vaidyanathan | COO & Executive Director |
Mr. Inderjeet Singh Negi | Executive Director |
Mr. Kaushal Shah | Executive Director |
Mr. Rajeev Dalal | Independent Director |
Mr. Vasudevan Sujesh | Independent Director |
Ms. Kalpana Unadkat | Independent Director |
Mr. Prashant Gupta | Independent Director |
Eris Lifesciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Eris Lifesciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-13 | Quarterly Results | |
2023-11-08 | Quarterly Results | |
2023-08-07 | Quarterly Results | |
2023-05-17 | Audited Results | |
2023-01-17 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2022-08-16 | INTERIM | Rs.7.35 per share(735%)Interim Dividend |
2021-08-06 | INTERIM | Rs.6.01 per share(601%)Interim Dividend |
Eris Lifesciences FAQs
What is Share Price of Eris Lifesciences ?
Eris Lifesciences share price is ₹843 As on 29 March, 2024 | 05:12
What is the Market Cap of Eris Lifesciences ?
The Market Cap of Eris Lifesciences is ₹11471.9 Cr As on 29 March, 2024 | 05:12
What is the P/E ratio of Eris Lifesciences ?
The P/E ratio of Eris Lifesciences is 29.7 As on 29 March, 2024 | 05:12
What is the PB ratio of Eris Lifesciences ?
The PB ratio of Eris Lifesciences is 5.2 As on 29 March, 2024 | 05:12